Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

121. Urinary tract infection (lower) - women

Urinary tract infection (lower) - women Urinary tract infection (lower) - women - NICE CKS Clinical Knowledge Summaries Share Urinary tract infection (lower) - women: Summary Lower urinary tract infection (UTI) is an infection of the bladder (also known as cystitis) usually caused by bacteria from the gastrointestinal tract. Acute uncomplicated UTI usually resolves within a few days. Risk factors for complicated UTI include: Structural or neurological abnormalities. Pregnancy. Urinary (...) referral made. In recurrent UTI: Referral should be made if cause is unknown, the woman is catheterized or malignancy suspected. Preventative measures such as behaviour and personal hygiene should be discussed — topical vaginal oestrogen and antibiotic prophylaxis may be appropriate. Have I got the right topic? Have I got the right topic? From age 16 years onwards (Female). This CKS topic covers the management of women with cystitis, asymptomatic bacteriuria, recurrent lower urinary tract infection

2014 NICE Clinical Knowledge Summaries

122. Urinary Tract Infection in Children - Radiological investigation following UTI

Urinary Tract Infection in Children - Radiological investigation following UTI ________________________________________________________________________________________________________________________ Diagnosis and Treatment of UTI in Children: Radiological Investigation September 2014 Page 1 of 17 DIAGNOSIS AND TREATMENT OF URINARY TRACT INFECTION IN CHILDREN: RADIOLOGICAL INVESTIGATION Date written: September 2014 Author: Michael Ditchfield, Sean Kennedy, Gabrielle Williams Scope of Guidelines (...) Specialist assessment and management is required for children who are considered at high risk of serious illness (underlying structural urinary tract abnormalities or neurogenic bladder or kidney transplant recipients). These children are beyond the scope of these guidelines and it is important that they are excluded from the recommendations detailed below. GUIDELINES a. We do not recommend routine renal tract imaging following a first urinary tract infection (UTI) except in the circumstances described

2014 KHA-CARI Guidelines

123. Urinary Tract Infection in Children - Diagnosis

Urinary Tract Infection in Children - Diagnosis ________________________________________________________________________________________________________________________ Diagnosis and Treatment of UTI in Children: Diagnosis September 2014 Page 1 of 23 DIAGNOSIS AND TREATMENT OF URINARY TRACT INFECTION IN CHILDREN: DIAGNOSIS Date written: September 2014 Author: Joshua Kausman, Margie Danchin Scope of Guidelines Specialist assessment and management is required for children who are considered (...) at high risk of serious illness (underlying structural urinary tract abnormalities or neurogenic bladder or kidney transplant recipients). These children are beyond the scope of these guidelines and it is important that they are excluded from the recommendations detailed below. GUIDELINES a. We recommend that the diagnosis of urinary tract infection (UTI) only be made on the basis of clinical symptoms (see below) in association with a positive urine culture. (1B) b. We suggest that the presence

2014 KHA-CARI Guidelines

124. Urinary Tract Infection in Children - Management & investigation of recurrent UTI/VUR

Urinary Tract Infection in Children - Management & investigation of recurrent UTI/VUR ________________________________________________________________________________________________________________________ Diagnosis and Treatment of UTI in Children: Long-term Management September 2014 Page 1 of 17 DIAGNOSIS AND TREATMENT OF URINARY TRACT INFECTION IN CHILDREN: LONG TERM MANAGEMENT – RECURRENT URINARY TRACT INFECTION AND VESICOURETIC REFLUX Date written: September 2014 Author: Gabrielle (...) for children after a first urinary tract infection (UTI). (1A) b. We suggest that antibiotic prophylaxis be considered in young infants with a severe index UTI and for children with recurrent UTI and/or Grades III-V vesicoureteric reflux (VUR). (2B) Surgical interventions for recurrent UTI c. We do not recommend routine circumcision for boys after a first UTI. (1B) d. We suggest that circumcision be considered for boys with recurrent UTI or high grade VUR. (2C) e. We do not recommend surgical interventions

2014 KHA-CARI Guidelines

125. Urinary Tract Infection in Children - Acute management

Urinary Tract Infection in Children - Acute management ________________________________________________________________________________________________________________________ Diagnosis and Treatment of UTI in Children: Acute Management September 2014 Page 1 of 13 DIAGNOSIS AND TREATMENT OF URINARY TRACT INFECTION IN CHILDREN: ACUTE MANAGEMENT Date written: September 2014 Author: Peter Trnka, Steven McTaggart Scope of Guidelines Specialist assessment and management is required for children who (...) are considered at high risk of serious illness (underlying structural urinary tract abnormalities or neurogenic bladder or kidney transplant recipients). These children are beyond the scope of these guidelines and it is important that they are excluded from the recommendations detailed below. GUIDELINES General a. We recommend starting treatment for presumed urinary tract infection (UTI) in children who have clinical symptoms suggestive of UTI and who have positive leukocyte esterase or nitrite on urinary

2014 KHA-CARI Guidelines

126. Diagnosis and Treatment of Urinary Tract Infection in Children

Diagnosis and Treatment of Urinary Tract Infection in Children KHA-CARI SUMMARY GUIDELINE – URINARY TRACT INFECTION IN CHILDREN. SEP 2014. Page | 1 This article is protected by copyright. All rights reserved. KHA-CARI Guideline Guideline title: Diagnosis and Treatment of Urinary Tract Infection in Children 1 Guideline authors: Steven McTaggart 1 , Margie Danchin 2,3 , Michael Ditchfield 4 , Ian Hewitt 5 , Joshua Kausman 6,7 , Sean Kennedy 8,9 , Peter Trnka 1,10 , Gabrielle Williams 11 . Running (...) Title: Urinary Tract Infection in Children Corresponding author: Steven McTaggart. Institution details E: Steven.McTaggart@health.qld.gov.au Tel: +63 7 3636 9219 Fax: +63 7 3636 1704 1 Child & Adolescent Renal Service, Royal Children's and Mater Children's Hospitals, University of Queensland, Brisbane, Australia. 2 Department of General Medicine, The Royal Children’s Hospital, Melbourne, Australia 3 Vaccine and Immunisation Research Group and Rotavirus Research Group, Murdoch Childrens Research

2014 KHA-CARI Guidelines

127. Cohort study: Renal and bladder ultrasound is important but yields incomplete screening for genitourinary abnormalities in young children with urinary tract infection

Cohort study: Renal and bladder ultrasound is important but yields incomplete screening for genitourinary abnormalities in young children with urinary tract infection Renal and bladder ultrasound is important but yields incomplete screening for genitourinary abnormalities in young children with urinary tract infection | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any (...) screening for genitourinary abnormalities in young children with urinary tract infection Article Text Diagnosis Cohort study Renal and bladder ultrasound is important but yields incomplete screening for genitourinary abnormalities in young children with urinary tract infection Sabah-e-Noor Servaes Statistics from Altmetric.com Commentary on: Nelson CP , Johnson EK , Logvinenko T , et al . Ultrasound as a screening test for genitourinary anomalies in children with UTI . Context The American Academy

2014 Evidence-Based Medicine (Requires free registration)

128. Multiple Sclerosis and Management of Urinary Tract Infection

Multiple Sclerosis and Management of Urinary Tract Infection MULTIPLE SCLEROSIS AND MANAGEMENT OF URINARY TRACT INFECTION Clinical Practice Guideline | November 2013 These recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. They should be used as an adjunct to sound clinical decision making. GOALS Urgent primary care assessment and management of urinary tract infections (UTIs (...) ) in patients with multiple sclerosis (MS) Preventing re-occurrence of UTIs TARGET POPULATION Adults with multiple sclerosis (MS) displaying signs and symptoms (typical and atypical) suggesting urinary tract infection (UTI) Adults with MS living in the community; ambulatory care setting EXCLUSIONS Institutionalized patients, i.e., nursing homes, long term care RECOMMENDATIONS ASSESSMENT X Do not wait to assess. ? Same day attention in primary care is strongly recommended. ? Assess for indicators of urinary

2014 Toward Optimized Practice

129. Cather-Associated Urinary Tract Infections: Definitions and Significance in the Urologic Patient

Cather-Associated Urinary Tract Infections: Definitions and Significance in the Urologic Patient Cather-Associated Urinary Tract Infections: Definitions and Significance in the Urologic Patient - American Urological Association advertisement Toggle navigation About Us About the AUA Membership AUA Governance Industry Relations Education AUAUniversity Education Products & Resources Normal Histology and Important Histo-anatomic Structures Urinary Bladder Prostate Kidney Renovascular Diseases (...) Academic Exchanges Giving Back Practice Resources Coding and Reimbursement Practice Managers' Network (PMN) Patient Safety and Quality of Care Accreditations and Reporting Patient Education Cather-Associated Urinary Tract Infections: Definitions and Significance in the Urologic Patient American Urological Association 1000 Corporate Boulevard Linthicum, MD 21090 Phone: 410-689-3700 Toll-Free: 1-800-828-7866 Fax: 410-689-3800 Email: Media Center Associate Websites Quick Links © 2019 American Urological

2014 American Urological Association

130. Zerbaxa (ceftolozane/tazobactam) - To treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI)

Zerbaxa (ceftolozane/tazobactam) - To treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI) Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - ZERBAXA (ceftolozane/tazobactam) Injection Company: Cubist Pharmaceuticals, Inc. Application No.: 206829 Approval Date: 12/19/2014 Persons with disabilities having problems accessing the PDF files below

2014 FDA - Drug Approval Package

131. Diagnosis and treatment of urinary tract infection in children

Diagnosis and treatment of urinary tract infection in children KHA-CARI MissioN CARING FOR AUSTRALASIANS WITH RENAL IMPAIRMENT Chronic Kidney Disease Guidelines DIAGNOSIS & TREATMENT OF UTI IN CHILDREN STATUS Nov 2014 Nov 2014 Nov 2014 Nov 2014 GUIDELINE SUMMARY . Steven McTaggart, Margie Danchin, Michael Ditchfield, Ian Hewitt, Joshua Kausman, Sean Kennedy, Peter Trnka1, Gabrielle Williams [accepted for publication] doi/10.1111/nep.12349 KHA-CARI Guidelines is located in the Centre for Kidney

2014 Clinical Practice Guidelines Portal

132. Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection

Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection Mitchell MD, Pegues DA, Umscheid CA Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation Mitchell MD, Pegues DA, Umscheid CA. Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection. Philadelphia: Center for Evidence-based Practice (CEP). 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Bacteriuria; Humans; Urinalysis; Urinary Tract Infections Language Published English Country of organisation United States English summary An English language summary

2014 Health Technology Assessment (HTA) Database.

133. History and physical examination plus laboratory testing for the diagnosis of adult female urinary tract infection (PubMed)

History and physical examination plus laboratory testing for the diagnosis of adult female urinary tract infection Emergency physicians often encounter females presenting with symptoms suggestive of urinary tract infections (UTIs). The diagnostic accuracy of history, physical examination, and bedside laboratory tests for female UTIs in emergency departments (EDs) have not been quantitatively described.This was a systematic review to determine the utility of history and physical examination (H&P

Full Text available with Trip Pro

2013 EvidenceUpdates

134. Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States (PubMed)

Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States The incidence of infected urolithiasis is unknown, and evidence describing the optimal management strategy for obstruction is equivocal.To examine the trends of infected urolithiasis in the United States, the practice patterns of competing treatment modalities, and to compare adverse outcomes.A weighted estimate of 396385 adult patients hospitalized with infected urolithiasis (...) was extracted from the Nationwide Inpatient Sample, 1999-2009.Time trend analysis examined the incidence of infected urolithiasis and associated sepsis, as well as rates of retrograde ureteral catheterization and percutaneous nephrostomy (PCN) for urgent/emergent decompression. Propensity-score matching compared the rates of adverse outcomes between approaches.Between 1999 and 2009, the incidence of infected urolithiasis in women increased from 15.5 (95% confidence interval [CI], 15.3-15.6) to 27.6 (27.4

2013 EvidenceUpdates

135. Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis

Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis Marschall J, Carpenter CR, Fowler S, Trautner BW CRD summary The review concluded that patients with short-term urinary catheterisation might benefit from antimicrobial prophylaxis following (...) catheter removal but it was important to identify the right patients. The authors acknowledged limitations in the review such as diverse populations and variation in treatment across studies. Their statement that it was difficult to make a standardised recommendation seems appropriate and reliable. Authors' objectives To assess whether administering prophylactic antibiotics at the time of urinary catheter removal reduced the risk of subsequent symptomatic urinary tract infection. Searching PubMed (1947

Full Text available with Trip Pro

2013 DARE.

136. Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis. (PubMed)

Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis. To determine whether antibiotic prophylaxis at the time of removal of a urinary catheter reduces the risk of subsequent symptomatic urinary tract infection.:Systematic review and meta-analysis of studies published before November 2012 identified through PubMed, Embase, Scopus, and the Cochrane Library; conference abstracts for 2006-12 were also reviewed.Studies were included if they examined (...) antibiotic prophylaxis administered to prevent symptomatic urinary tract infection after removal of a short term (≤ 14 days) urinary catheter.Seven controlled studies had symptomatic urinary tract infection after catheter removal as an endpoint; six were randomized controlled trials (five published; one in abstract form) and one was a non-randomized controlled intervention study. Five of these seven studies were in surgical patients. Studies were heterogeneous in the type and duration of antimicrobial

Full Text available with Trip Pro

2013 BMJ

137. Multidrug resistant urinary tract infections: fosfomycin trometamol

Multidrug resistant urinary tract infections: fosfomycin trometamol Multidrug resistant urinary tract infections: fosfomycin trometamol | Advice | NICE Multidrug resistant urinary tract infections: fosfomycin trometamol Evidence summary [ESUOM17] Published date: July 2013 Advice This evidence summary has been withdrawn because a product containing fosfomycin trometamol with a marketing authorisation for treating multidrug resistant urinary tract infections is now available in the UK. Explore ©

2013 National Institute for Health and Clinical Excellence - Advice

138. Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines

Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA (...) . No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary of Abstracts. 2013 Authors' conclusions One systematic review regarding the effectiveness and safety of gentamicin treatment administered via bladder instillation for the treatment

2013 Health Technology Assessment (HTA) Database.

139. Systematic review and meta-analysis: Use of cranberry products does not appear to be associated with a significant reduction in incidence of recurrent urinary tract infections

Systematic review and meta-analysis: Use of cranberry products does not appear to be associated with a significant reduction in incidence of recurrent urinary tract infections Use of cranberry products does not appear to be associated with a significant reduction in incidence of recurrent urinary tract infections | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time (...) reduction in incidence of recurrent urinary tract infections Article Text Therapeutics Systematic review and meta-analysis Use of cranberry products does not appear to be associated with a significant reduction in incidence of recurrent urinary tract infections Armando J Lorenzo 1 , Luis H P Braga 2 Statistics from Altmetric.com Commentary on: Jepson RG , Williams G , Craig JC . Cranberries for preventing urinary tract infections . Context Urinary tract infections (UTIs) represent a considerable

2013 Evidence-Based Medicine (Requires free registration)

140. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antisepticimpregnated urethral

Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antisepticimpregnated urethral Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial

2012 NIHR HTA programme